학술논문
Does HER2 status influence in the benefit of ramucirumab and paclitaxel as second line treatment of advanced gastro-esophageal adenocarcinoma? Data from the AGAMENON-SEOM registry
Document Type
Journal
Author
Valcarcel, Sena; Gallego, Javier; Jimenez-Fonseca, Paula; Diez, Marc; Martinez de Castro, Eva; Hernandez, Raquel; Arrazubi, Virginia; Custodio, Ana; Maria Cano, Juana; Fernandez Montes, Ana; Macias, Ismael; Visa, Laura; Calvo, Aitana; Vidal Tocino, Rosario; Martinez Lago, Nieves; Luisa Limon, Maria; Granja, Monica; Gil, Mireia; Pimentel, Paola; Macia-Rivas, Lola; Perez, Carolina Hernandez; Mangas, Montserrat; Martin Carnicero, Alfonso; Cerda, Paula; Gomez Gonzalez, Lucia; Garcia Navalon, Francisco; Mediano Rambla, Ma Dolores; Martin Richard, Marta; Carmona-Bayonas, Alberto
Source
Subject
Language
English
ISSN
14321335